Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.
D000241:Adenosine / Q000494:pharmacology; D000249:Adenosine Monophosphate / Q000494:pharmacology; D000633:Aminopyrine N-Demethylase / Q000032:analysis; D000814:Aniline Compounds; D000818:Animals; D000242:Cyclic AMP / Q000008:administration & dosage / Q000494:pharmacology*; D065607:Cytochrome P-450 Enzyme Inhibitors; D003580:Cytochromes / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006591:Hexobarbital / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000032:analysis; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D051381:Rats; D012737:Sex Factors; D013056:Spectrophotometry, Ultraviolet
D000814:Aniline Compounds; D065607:Cytochrome P-450 Enzyme Inhibitors; D003580:Cytochromes; D000249:Adenosine Monophosphate; D006591:Hexobarbital; D000242:Cyclic AMP; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D000633:Aminopyrine N-Demethylase; D000241:Adenosine